Abstract

7003Background: We have previously reported high anti-tumor activity of CD19-targeted 19-28z chimeric antigen receptor (CAR) modified T cells in adult patients (pts) with relapsed or refractory (R/...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call